Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
Incyte Corporation
Incyte Corporation
Merck Sharp & Dohme LLC
Shanghai Bovax Biotechnology Co., Ltd.
Beijing Health Guard Biotechnology, Inc
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc